Are you Dr. Burnette?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 103 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
835 S Van Buren St
Green Bay, WI 54301Phone+1 920-432-6049
Summary
- Dr. Brian Burnette, MD is an oncologist in Green Bay, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Michigan, and Minnesota. He is affiliated with HSHS St. Vincent Hospital, HSHS St. Clare Memorial Hospital, and OSF St. Francis Hospital and Medical Group.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Michigan State University College of Human MedicineClass of 2006
Certifications & Licensure
MI State Medical License 2013 - 2026
WI State Medical License 2013 - 2025
MN State Medical License 2007 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsA decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumabTimothy J. Poterucha, Brian L. Burnette, Aminah Jatoi
Medical Oncology. 2012-06-01 - 76 citationsRandomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuva...Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park
Journal of Clinical Oncology. 2021-06-06 - 73 citationsRenal Improvement in Myeloma with Bortezomib plus Plasma ExchangeBrian L. Burnette, Nelson Leung, S. Vincent Rajkumar
The New England Journal of Medicine. 2011-06-15
